BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16432775)

  • 21. [Enzyme replacement therapy in Fabry's disease].
    Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
    Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women.
    Havndrup O; Christiansen M; Stoevring B; Jensen M; Hoffman-Bang J; Andersen PS; Hasholt L; Nørremølle A; Feldt-Rasmussen U; Køber L; Bundgaard H
    Eur J Heart Fail; 2010 Jun; 12(6):535-40. PubMed ID: 20498269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fabry disease: diagnostic due of substitutive enzyme-therapy].
    Barbey F; Widmer U; Burnier M; Lidove O
    Rev Med Suisse Romande; 2002 Sep; 122(9):449-53. PubMed ID: 12422475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabry disease. A case report.
    Kotnik J; Kotnik F; Desnick RJ
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):15-9. PubMed ID: 15818441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kidney in Fabry's disease.
    Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
    Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vitro model of Fabry disease.
    Shu L; Murphy HS; Cooling L; Shayman JA
    J Am Soc Nephrol; 2005 Sep; 16(9):2636-45. PubMed ID: 16033856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fabry disease].
    Jakubowska E; Ryba M; Hruby Z
    Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes.
    Kim JH; Lee BH; Hyang Cho J; Kang E; Choi JH; Kim GH; Yoo HW
    J Hum Genet; 2016 Nov; 61(11):923-929. PubMed ID: 27334365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fabry disease].
    Kantola I; Penttinen M; Nuutila P; Viikari J
    Duodecim; 2012; 128(7):729-39. PubMed ID: 22612023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of cornea verticillata in hemizygotes of a novel mutation in fabry disease.
    Huerva V; Martín M; Canto LM; Yagüe J
    Cornea; 2008 Sep; 27(8):970-2. PubMed ID: 18724168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
    Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
    Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fabry disease--a diagnostic and therapeutic challenge].
    Houge G; Skarbøvik AJ
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1004-6. PubMed ID: 15852071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma globotriaosylsphingosine as a biomarker of Fabry disease.
    Togawa T; Kodama T; Suzuki T; Sugawara K; Tsukimura T; Ohashi T; Ishige N; Suzuki K; Kitagawa T; Sakuraba H
    Mol Genet Metab; 2010 Jul; 100(3):257-61. PubMed ID: 20409739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: a case report.
    Dziemianko I; Jezior D; Boratyńska M; Patrzałek D; Kuźniar J; Szyber P; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2925-7. PubMed ID: 18022018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiokeratoma corporis diffusum (Fabry disease).
    Karen JK; Hale EK; Ma L
    Dermatol Online J; 2005 Dec; 11(4):8. PubMed ID: 16403380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A diagnosis of Fabry gastrointestinal disease by chance: a case report.
    Feriozzi S; Torre ES; Ranalli TV; Cardello P; Morrone A; Ancarani E
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):163-5. PubMed ID: 17273003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anderson-Fabry disease: developments in diagnosis and treatment.
    Kes VB; Cesarik M; Zavoreo I; Madzar Z; Demarin V
    Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrative review: Fabry disease.
    Clarke JT
    Ann Intern Med; 2007 Mar; 146(6):425-33. PubMed ID: 17371887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.